PRHSX Mutual Fund

PRHSX Mutual Fund

NAV$101.07
See how much of PRHSX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Returns Overview

1 Month
+6.85%
3 Months
+12.32%
6 Months
+26.56%
YTD
+20.54%
1 Year
+29.09%
3 Years (annualized)
+17.49%
5 Years (annualized)
+5.08%
10 Years (annualized)
+12.77%

Risk Metrics (1-Year)

No risk data available for this Mutual Fund

Stress Test Scenarios

How would PRHSX have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
PROUpgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
PROUpgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
PROUpgrade to run

1 Month Performance

3 Months Performance

6 Months Performance

1 Year Performance

Benchmark & Peers

Benchmark
Lipper Health/Biotechnology Funds Index
This Mutual Fund (YTD)
+20.54%
Peer Avg (YTD)
+12.41%
vs Peers
+8.13%

PRHSX Mutual Fund Performance

PRHSX performance across multiple time periods: 1-month 6.85%, YTD 20.54%, 1-year 29.09%, 3-year 17.49%, 5-year 5.08%, 10-year 12.77%.

PRHSX returns outperform the peer average of 12.41% YTD. With an expense ratio of 0.80%, investors should weigh costs against performance when evaluating this mutual fund.

PRHSX vs another fund shows side-by-side returns. PRHSX alternatives are available in the Mutual Fund Screener.